Parth Shah @ParthSharesBio
Biotech exec sharing views on #healthcare #biopharma #leadership | Posts are my own linkedin.com/in/parthrshah California, USA Joined September 2013-
Tweets353
-
Followers244
-
Following321
-
Likes962
Nike put out this memo in 1977. Sales rose 34,400% over the next 25 years.
.@JensenHuang is a national treasure 🫡
1/ The first drug ever built to lower Lp(a) just failed its outcomes trial. The drug did exactly what it was designed to do. That is what makes this result so uncomfortable.
The answer is that all healthcare contracts should be made public, including pricing and all Non Profit hospitals should be required to publish their General Ledger Entries and purchasing reports. They take taxpayer money and avoid taxes. It's a fair exchange that would educate us all enough to answer your questions and make better decisions
More employers are dropping the largest PBMs axios.com/2026/08/12/mor…
2025 @IQVIA_Institute analysis: 90% of biologics losing exclusivity in the next decade have no #biosimilar competition—creating a dangerous #biosimilarvoid. Policymakers must act now to cut barriers & expand access: iqvia.com/Insights/The-I…
In Nature Medicine, a new perspective from researchers at @Stanford, @Google, and leading experts across major AI labs and academic institutions, explores the need for a rigorous, task-based framework to define and measure medical AI: goo.gle/3REZ4VJ
Today, The Council, along with @AccessibleMeds, lauded legislative progress as the House Energy and Commerce Committee marked up and voted to approve the Expedited Access to Biosimilars Act and the Biosimilars Red Tape Elimination Act. These bills were passed out of the committee unanimously and are now ready for a vote by the full House of Representatives. The Biosimilars Red Tape Elimination Act was voted out of the Senate Health Committee last week and is also ready for a vote of the full Senate. @HouseCommerce
We are just getting started. As our volumes go up, our prices go down. And we are adding more branded meds and soon more specialty meds. If you use humira, stelara or other meds that have biosimilars, we are most likely far cheaper than what you or your company pay now
I’m know by now most are aware of @mcuban @costplusdrugs but every day these testimonials amaze me (and bum me out a little)
“The Expedited Access to Biosimilars Act would codify the FDA's science-based approach to biosimilar review by limiting comparative efficacy studies.” More from Chain Drug Review: chaindrugreview.com/biosimilars-co…
NEW: Optum is partnering with Anthropic to deploy Claude across its healthcare operations. The companies say they’ll use frontier AI to reduce administrative burden, improve patient interactions, and support clinicians.
Big day today at Anthropic. A few takeaways 1. They're going to start rare disease therapeutics 2. Their bio agent goes from raw data to a paper 3. They're making Claude code a central node for access in Bio tools 4. They have a hackathon for Claude bio agent soon see image for qr code
Satya Nadella talks about the token economy. Dario Amodei predicts an abundance of new drugs thanks to AI agents. As tokens and agents transform the economics of entire industries, what makes genetic medicine particularly well-positioned to benefit from industrial-scale reasoning? Modularity. Every component, including operational workflows, can be optimized, de-risked, and improved independently, then reused across programs. In a new Substack post, we describe how we’re collaborating with @NVIDIAHealth to build a new infrastructure stack for genetic medicine – lowering the barriers to entry for drugs that were once considered economically infeasible. Read more: dynotx.substack.com/p/genetic-medi…
118 biologics losing exclusivity before 2035….but only 12 biosimilar markers confirmed in development. The gap is real with implications for innovator and biosimilar manufacturers. #biotech
A 2025 @IQVIA_Institute report showed 118 biologics (loosing exclusivity before 2035) with only 12 biosimilars in development. Closing this #biosimilarvoid means action from manufacturers, payers, providers & policymakers. MORE: accessiblemeds.org/resources/blog… #GRxBiosimsSavingsReport
A biosimilar can now reach the US market without a single head-to-head clinical efficacy trial against its reference product. The evidence that replaces it now lives inside the analytical lab. Read more: sh.bgs.group/4hl #AUTOMAplus2026 #Biosimilars #FDA #Digitalisation
On #biosimilars adoption “MedImpact is moving to change that, he added, by advancing a therapeutic interchange-based formulary strategy focused on the roughly 2% to 5% of claims that drive 50% of spend.”
Could biosimilars reshape specialty drug spending? New data points to significant savings potential—but only if adoption hurdles can be overcome. Learn what's next. 👇 specialtypharmacycontinuum.com/a/8zoBAA/t #pharmacy #biosimilars
I will add and say the “enduring moat” is 1) end to end commercialization including go to market efforts 2) the judgement of which ideas the market needs and will pay for #biotech #pharma
"AI will transform pharma, but not evenly and not all at once." "Building an enduring company in the age of AI is hard precisely because advantages can dissipate rapidly as models improve." "The companies that win will predict the uneven frontiers correctly, absorbing each
@vijaypande Getting close:
Can bio foundation models solve the most critical therapeutics problem, predicting which patients will respond to a therapy? Today, we share more details in a white paper on our recently reported results using @NOETIK_ai TARIO-2 to predict responders in an actual clinical trial
Wearable technologies are increasingly being integrated into clinical trials. This Review in the June issue covers this evolving landscape, including the translational pathways for wearable-derived measures in drug development nature.com/articles/s4157… rdcu.be/foTjR
SubLine 🪻👑🍒�... @syara76508
25 Followers 1K Following If you want to quickly turn $10,000 into $1,000,000, follow the link below to join us and learn more details.👇 👇🏼💦🍂
Sophia @gsept2869
0 Followers 299 Following nursing student by day 🩺 iced coffee addict, true crime podcasts & a side of me the study group hasn't seen
Ashwin Sharma @Ashwinreads
12K Followers 916 Following Founder @glp1digest / D2C & GLP-1 biotech research: https://t.co/upg2T0iLea / Building https://t.co/NWwzeoUwvU / Writing @every / MD & Ex-VC fellow
Ron Alfa @Ronalfa
7K Followers 3K Following CEO & Co-founder @NOETIK_AI Using AI to actually solve cancer.
Matt Schwartz @matt_is_nice
2K Followers 3K Following Using AI to tackle GI cancers and chronic diseases. Co-founder of Zaniah Health (at-home capsule endoscopy) and Virgo (AI for endoscopy)
CRISPRKing @CRISPRKING
11K Followers 7K Following Building open-source pipelines to prove drug targets are real. AI × Bioinformatics × Chemical Biology × Medicine.
Liang Chang @liangc_science
1K Followers 2K Following AIxBiotech @ForesiteLabs @ForesiteCapital | PhD from @Harvard | Writing on https://t.co/DsbBBbz67V | Views are my own
PeachyLuna @RochelleSlaugh1
124 Followers 1K Following We cannot control how others behave, but we can choose how we respond to them and what kind of people we allow into our lives.
Sylvain Gariel @SylvainGariel
1K Followers 3K Following Building at the intersection of AI for Science and Drug Discovery. Based in San Francisco. Venture Partner @Frst_vc
Cam the Ham @Staniron
225 Followers 2K Following soft girl with a sharp tongue 🗡️ always follow back
@BioAI_Neuro @BioAI_NeuralNet
16K Followers 8K Following @MIT trained Neuroscientist interested #Neural_Nets, #BioAI, #NeuroAI 🧠⚡🤖 https://t.co/mrNBAVydzT 🎯 [email protected]
Sam Davis @SamDavisBio
2K Followers 1K Following Building CoFormBio | Ex-EQRx (exit), Ex-Scipher, Ex-Goodwin
Numeratili @numeratili
22 Followers 1K Following Lifelong Learner and Explorer across Science and Business Analytics using AI, ML, and Data Science to Help Decision Making
OmVenture @OmVenture
10K Followers 3K Following Investing & financing proteomics, genomics, biotech & pharma for drugs, medical, prevention, diagnostic, healthcare & longevity using super intelligent ventures
Kate Stafford @kastacholamine
2K Followers 3K Following Something new in AI x bio. 🌈 Past: VP ML @Numerionlabsai (fka Atomwise), UCSF, Columbia, DE Shaw Research, MIT.
Frances Ivan @FrancesIva40354
0 Followers 23 Following
Gal Gadot @Galdgadotgj
942 Followers 5K Following Like a butterfly, pretty to see. Down to earth. I am who i am. Wonder Woman MovieBox🎥
Fraudster Ron Cohen @CarlMarxie
1K Followers 6K Following If anyone is interested in committing FRAUD contact me Ron Cohen or my colleague Michael Gesser. My main number is 917-757-9896.I’m on the run currently.
Antibody News @antibodynewshq
255 Followers 5K Following
Uma Kothapalli @Uma_Kothapalli
1 Followers 16 Following
Lea @Ykaaufa302
248 Followers 7K Following
Agnes @kp67E52xzf28P
27 Followers 830 Following
RetailFlowPro🇺🇸 @Algercir602
56 Followers 2K Following 15-30% Monthly | 2 High-Conviction Stocks.Short-Term Gains: 15-20% in Days/Weeks.DM "JOIN" for WhatsApp Alerts. Live Trade Signals • Market Analysis
DaphneDutt @198G0p801wpa6
37 Followers 1K Following
Alessia @Gorja564505
109 Followers 2K Following I’m not a one in a million kind of girl, I’m a once in a lifetime kind of woman.
Sophia ova @Sophiaova1
461 Followers 3K Following Don't forget why you set out because you've walked too far🚶♀️
Mary linder @FRMarylinder
187 Followers 2K Following Goldman Sachs | Financial Analytics | Financial Framework Building | Like to Meet New People | Her
Aswath Damodaran @AswathlDamdaran
552 Followers 7K Following Fascinated by finance & markets and like writing about them, but teaching is my passion.
Riodeevoa @Riodeevoaf9uW
60 Followers 4K Following
Arham Foundation Trus... @Arhamfdn
160 Followers 4K Following Why Arham Foundation is the BEST? Because Team of genius and dedicated youngsters The social workers team with great capacity working in innermost Rural areas.
Daisy Smirnova @daisysmijkfcbcr
92 Followers 5K Following When you have a dream, you've got to grab it and never let go! No Bots⛔️ No Porn ⛔️ will be blocked ⛔️
Twilight🌅 @WeningSpark
102 Followers 447 Following Designer from Indonesia, realizing my dream in Manhattan. Single, colorful! 🎨✨
Yang @Jack_yang_999
264 Followers 1K Following
DeborahPeg @yN2g8o1KLo6tj
79 Followers 7K Following
Causmoo @Causmoo43Kn
261 Followers 5K Following
Ross V. Chikarmane @rvchikar
446 Followers 2K Following 🧬 Biotech company builder, investor, scientist |🔬 PhD @HopkinsMedicine | Views my own
MadgeWebb @VEz98VMoAp8jZ25
66 Followers 7K Following
Soothoez @Soothoez7cNFRU
53 Followers 5K Following
Thetert @ThetertKGs4
48 Followers 4K Following
Sean @sean_________
10K Followers 3K Following TMT catalyst/event-driven trader with a focus on research.
Linda Yaccarino @lindayaX
847K Followers 2K Following CEO of eMed Population Health, Mom, foodie, fashion enthusiast, @penn_state alum, former CEO of X
Ashwin Sharma @Ashwinreads
12K Followers 916 Following Founder @glp1digest / D2C & GLP-1 biotech research: https://t.co/upg2T0iLea / Building https://t.co/NWwzeoUwvU / Writing @every / MD & Ex-VC fellow
Kiran Mazumdar-Shaw @kiranshaw
1.5M Followers 748 Following Executive Chairperson of Biocon Limited - Asia’s leading Biopharmaceuticals enterprise. A global influencer and proud recipient of Padma Shri & Padma Bhushan.
Eric Percher @EPercher
32 Followers 76 Following @NephronResearch + COVID-19 Daily Tracker. Parsing healthcare data. Lots of it!
Sofia Guerra @SofiaGuerraR
2K Followers 586 Following Partner @BessemerVP | Healthcare and life sciences | Co-founder @NucleateHQ | Former @HarvardHBS, @Harvard, @BainAlerts, @Roughdraftvc @BoxGroup
Nephron Research LLC @NephronResearch
528 Followers 82 Following Essential to our clients' investment process via the production of insightful research, impactful financial analyses, and innovative corporate access
Mark Zuckerberg @finkd
2.5M Followers 759 Following
Ron Alfa @Ronalfa
7K Followers 3K Following CEO & Co-founder @NOETIK_AI Using AI to actually solve cancer.
Vijay Pande @vijaypande
36K Followers 1K Following Co-Founder at @VZVCfund. Investing in companies solving humanity’s biggest problems, led by founders hell bent on bending the curve.
Marcus Goncalves @MarcusDGon
3K Followers 766 Following MD/PhD Endocrinologist Scientist. Cancer metabolism, cachexia, insulin, PI3K, diabetes, obesity. GI Villi lover. Metabolic Consulting. NYJ/NYY/NYCFC/NYK fan.
David Sinclair @davidasinclair
663K Followers 1K Following Professor researching why we age & how to reverse it. Author & host of Lifespan. Mission: Extend healthy life for all. Views are entirely his own. @joinlifespan
Matt Schwartz @matt_is_nice
2K Followers 3K Following Using AI to tackle GI cancers and chronic diseases. Co-founder of Zaniah Health (at-home capsule endoscopy) and Virgo (AI for endoscopy)
CRISPRKing @CRISPRKING
11K Followers 7K Following Building open-source pipelines to prove drug targets are real. AI × Bioinformatics × Chemical Biology × Medicine.
Vineeta Agarwala @vintweeta
24K Followers 1K Following gp @a16z bio | physician, adjunct clinical prof @stanfordmed | prev @gvteam, product @flatironhealth, mdphd @broadinstitute | out-tweeting @paraga @littleansh
Liang Chang @liangc_science
1K Followers 2K Following AIxBiotech @ForesiteLabs @ForesiteCapital | PhD from @Harvard | Writing on https://t.co/DsbBBbz67V | Views are my own
Sylvain Gariel @SylvainGariel
1K Followers 3K Following Building at the intersection of AI for Science and Drug Discovery. Based in San Francisco. Venture Partner @Frst_vc
Feroce Research @FeroceResearch
18K Followers 105 Following Turning Hindsight Into Foresight | Thematic Investing | Combining Technicals + Macros & Fundamentals + Quantitative Positioning
Pradeep Natarajan @pnatarajanmd
29K Followers 801 Following VP, Head of Cardiometabolic Research, Head of Human Genetics @Amgen
The Assembly @InTheAssembly
565K Followers 20 Following Macro analysis, market structure, and the trades nobody else is showing you. Not financial advice.
Global Markets Invest... @GlobalMktObserv
96K Followers 63 Following Global Markets Investor is a financial research platform covering global markets and economies. Founded by a Wall Street equity and macro research professional.
@BioAI_Neuro @BioAI_NeuralNet
16K Followers 8K Following @MIT trained Neuroscientist interested #Neural_Nets, #BioAI, #NeuroAI 🧠⚡🤖 https://t.co/mrNBAVydzT 🎯 [email protected]
Matthew Kirshner @MattyKirsh
3K Followers 1K Following Deploying AI in bio for real world impact. Bridging MT / CA / NY. Not investment advice 🧬🏔️🦠
Osprey Capital @MBbiotech
4K Followers 4K Following Healthcare Equity Investing. Tweets are not investment advice. May buy or sell any security without any disclosures.
Yuval Cohen @CEOCorbus
2K Followers 896 Following I'm the CEO of @CorbusPharma ($CRBP). I'm passionate about inflammatory/fibrotic/metabolic diseases and cancer. These opinions are my own.
Bharath T. @PreemptDisease
262 Followers 641 Following Founder building complex nano-bio-ML products, towards disease preemption (detect & cure before full disease onset). https://t.co/ul0mf5Jqsk - scaled high-res SPR kinetic data
Ben Pouladian @benitoz
25K Followers 1K Following AI Infrastructure • Compute Economics • Semiconductors • Models • Power • $NVDA since 2016
Samuel Hume @DrSamuelBHume
62K Followers 2K Following Doctor, scientist | Trying to speed up science and solve disease
AAM @AccessibleMeds
13K Followers 2K Following Association for Accessible Medicines promotes policies to ensure generic & biosimilar medicines are accessible to people who need them.
TwoOncDocs @TwoOncDocs
5K Followers 2K Following 🩸 a podcast about heme/onc for health care providers | ☕️ short high yield episodes to supplement your board review resources | @SamArmstrongMD @DrKarineTawagi
Danielle Bitterman, M... @dbittermanmd
1K Followers 641 Following Leading AI for Clinical Trials at AstraZeneca | Physician | Previously Harvard Med & Mass General Brigham
OpenEvidence @OpenEvidence
38K Followers 400 Following OpenEvidence is the most popular AI for doctors in the United States. Founded with the mission to organize and expand the world's collective medical knowledge.
Jason Kelly @jrkelly
34K Followers 3K Following Co-founder and CEO at Ginkgo Bioworks ($DNA)🧬 Former Chair of US National Security Commission on Emerging Biotechnology 🇺🇸
Samarth @samarthathreya
761 Followers 359 Following Technology and Life Sciences | Fellow @thielfellowship
Sanat Mishra @sanatmishra7
700 Followers 1K Following RL for healthcare @getbiostack. Prev @Stanford @Yale @CarnegieMellon
Aaron Edwards @aedwards02
2K Followers 2K Following Building noise-cancelling headphones for cell therapies @KiraGenBio starting with glioblastoma @HarvardHBS • @BeamTx • @BluebirdBio
Sam Davis @SamDavisBio
2K Followers 1K Following Building CoFormBio | Ex-EQRx (exit), Ex-Scipher, Ex-Goodwin
Rich Law @drrichjlaw
5K Followers 2K Following CBO of Haya Therapeutics! (formerly Exscientia/Recursion CBO), PhD computational chemist, MBA, BD, (Oxford, UCSD, LLNL & Evotec), bike racer & LFC fan! #YNWA
John Maraganore 🇺�... @JMaraganore
17K Followers 425 Following Founding CEO of @Alnylam. Pioneered RNAi therapeutics as a whole new class of medicines for patients. Now bioentrepreneur-at-large. Opinions are my own.
Alex Karnal @alex_karnal
2K Followers 70 Following Co-Founder and Chief Investment Officer at Braidwell. Building and backing solutions to humanity’s toughest, science-driven problems.
Michael Albert, MD @MichaelAlbertMD
22K Followers 2K Following Physician Executive | Co-Founder | Building the future of physician-owned healthcare at Vineyard
Brad Loncar @bradloncar
83K Followers 369 Following #Biotech, Founder of @BiotechTV, KC native, @univmiami hurricane.🧬🙌
Sally Church @MaverickNY
18K Followers 2K Following Scientist, oncology geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & footballYou might like
